文献速递自身炎症与 IgG4 相关病

家族性地中海热患者肠道菌群改变与表型和基因型相关

Gut microbiota alterations are associated with phenotype and genotype in familial Mediterranean fever.
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

该研究对119例家族性地中海热(FMF)患者和61名健康对照进行16S rRNA基因测序,分析肠道菌群与疾病特征及基因型的关联。结果显示FMF患者肠道菌群中促炎菌群增多,疾病特征和秋水仙碱抵抗与纯合突变及特定菌群改变相关,秋水仙碱治疗与抗炎菌群扩增相关,病情严重度与瘤胃球菌gnavus组和副球菌属扩增相关。

要点

  • FMF患者肠道菌群较健康对照有促炎细菌增多,如肠杆菌属、克雷伯菌属和瘤胃球菌gnavus组。
  • 疾病特征和秋水仙碱抵抗与纯合MEFV突变相关,并伴随特定菌群改变。
  • 秋水仙碱治疗与抗炎菌群(如粪杆菌属和罗斯氏菌属)扩增相关,而FMF严重度与瘤胃球菌gnavus组和副球菌属扩增相关。

核心结论

  • FMF患者肠道菌群与疾病特征和严重度相关,最严重患者中促炎菌群增多。
  • 这提示肠道菌群在塑造FMF结局和治疗反应中可能起特定作用。

研究设计与样本

  • 研究纳入119例FMF患者和61名健康对照,采用16S rRNA基因测序分析肠道菌群。
  • 使用MaAslin2多变量线性模型评估细菌分类群与临床特征及基因型的关联,并校正年龄、性别、基因型、AA淀粉样变性(n=17)、肝病(n=5)、秋水仙碱摄入、秋水仙碱抵抗(n=27)、生物制剂使用(n=10)、CRP水平和每日排便次数。
  • 同时分析细菌网络结构。

主要发现

  • FMF患者肠道菌群与对照不同,促炎细菌增多,如肠杆菌属、克雷伯菌属和瘤胃球菌gnavus组。
  • 疾病特征和秋水仙碱抵抗与纯合突变相关,并与特定菌群改变相关。
  • 秋水仙碱治疗与抗炎分类群如粪杆菌属和罗斯氏菌属的扩增相关,而FMF严重度与瘤胃球菌gnavus组和副球菌属的扩增相关。
  • 秋水仙碱抵抗患者表现出细菌网络结构改变,分类群间连接性降低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: FMF is the most common monogenic autoinflammatory disease associated with MEFV mutations. Disease phenotype and response to treatment vary from one patient to another, despite similar genotype, suggesting the role of environmental factors. The objective of this study was to analyse the gut microbiota of a large cohort of FMF patients in relation to disease characteristics. METHODS: The gut microbiotas of 119 FMF patients and 61 healthy controls were analysed using 16 s rRNA gene sequencing. Associations between bacterial taxa, clinical characteristics, and genotypes were evaluated using multivariable association with linear models (MaAslin2), adjusting on age, sex, genotype, presence of AA amyloidosis (n = 17), hepatopathy (n = 5), colchicine intake, colchicine resistance (n = 27), use of biotherapy (n = 10), CRP levels, and number of daily faeces. Bacterial network structures were also analysed. RESULTS: The gut microbiotas of FMF patients differ from those of controls in having increased pro-inflammatory bacteria, such as the Enterobacter, Klebsiella and Ruminococcus gnavus group. Disease characteristics and resistance to colchicine correlated with homozygous mutations and were associated with specific microbiota alteration. Colchicine treatment was associated with the expansion of anti-inflammatory taxa such as Faecalibacterium and Roseburia, while FMF severity was associated with expansion of the Ruminococcus gnavus group and Paracoccus. Colchicine-resistant patients exhibited an alteration of the bacterial network structure, with decreased intertaxa connectivity. CONCLUSION: The gut microbiota of FMF patients correlates with disease characteristics and severity, with an increase in pro-inflammatory taxa in the most severe patients. This suggests a specific role for the gut microbiota in shaping FMF outcomes and response to treatment.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Delplanque M, Benech N, Rolhion N, et al. Gut microbiota alterations are associated with phenotype and genotype in familial Mediterranean fever. Rheumatology (Oxford). 2024. PMID: 37402619. doi:10.1093/rheumatology/kead322

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。